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Abstract
Background: The patchy nature of villous lesion in celiac disease is increasingly being recognized.
Current guidelines recommend four endoscopic duodenal mucosal biopsies from the second or
more distal part of the duodenum to confirm the diagnosis of celiac disease. The purpose of the
study was to investigate the usefulness of duodenal bulb mucosal biopsies in confirming the
diagnosis of celiac disease in everyday clinical practice.
Methods:  All patients with a positive tissue-transglutaminase antibody requiring biopsy-
confirmation of celiac disease over a two-year period were studied. Two endoscopic biopsies were
taken from the duodenal bulb and four biopsies from the second (or distal) part of the duodenum.
Results: Thirty-five patients were included, mean age 8.1 (± 4.7) years. Thirty-one (88.6%) patients
had abnormal distal duodenal biopsies, one had Marsh type 1, one had Marsh type 2 and twenty-
nine had Marsh type 3 lesion. All but two patients with abnormal distal duodenal biopsies also had
abnormal bulb biopsies. Four (11.4%) patients had normal distal duodenal biopsies but abnormal
bulb biopsies. Of these, one patient had Marsh type 2 and three had Marsh type 3 lesion. The distal
duodenum was also grossly normal in these four patients. The histological diagnosis of celiac
disease would not have been possible in these four cases with distal duodenal biopsies only.
Conclusion: The lesion in celiac disease in children can be patchy with duodenal bulb mucosa
being the only area showing histological changes. The recommendations regarding the site of
biopsies should be revised to include biopsies not only from distal duodenum but also from bulb
to improve the diagnostic yield.
Background
Celiac disease (gluten-sensitive enteropathy) is a chronic
gastrointestinal disorder in which ingestion of gluten, a
protein present in wheat, rye and barley, leads to damage
of the small intestinal mucosa by an autoimmune mech-
anism in genetically susceptible individuals. Although
highly sensitive serological tests are available for screen-
ing, small intestinal biopsies are essential to confirm the
diagnosis of celiac disease [1].
The patchy nature of villous lesion in celiac disease is
increasingly being recognized. The current guidelines
(American Gastroenterological Association Technical
Review 2006, North American Society for Paediatric Gas-
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troenterology, Hepatology and Nutrition 2005) recom-
mend that mucosal biopsies be taken from the second or
more distal part of the duodenum for histological exami-
nation [2,3]. A minimum of four biopsy specimens is rec-
ommended. Multiple biopsies are needed to limit
problems with orientation of the specimens and artefact
during processing and staining.
Although the role of duodenal bulb biopsies in confirm-
ing celiac disease has been assessed in a few prospective
research studies, no information is available on the out-
come of applying this biopsy strategy in everyday, routine
clinical practice where several different pathologists may
be involved in reporting histological findings. The aim of
the study was to investigate the usefulness of duodenal
bulb mucosal biopsies in confirming the diagnosis of
celiac disease in clinical practice.
Methods
A previous report by Bonamico et al [4] showing the use-
fulness of duodenal bulb biopsies in the diagnosis of
celiac disease had prompted the author (M.R.) to revise
clinical practice by obtaining two additional biopsies
from the duodenal bulb in cases of suspected celiac dis-
ease.
All patients with a positive tissue-transglutaminase (TTG)
antibody test requiring biopsy-confirmation of celiac dis-
ease over a two-year period were retrospectively reviewed.
The patients were all on a normal (gluten-containing) diet
at the time of biopsy. Each patient had two endoscopic
biopsies taken from the duodenal bulb and four biopsies
from the second (or distal) part of the duodenum. Two
biopsies were also taken from the gastric antrum for any
Helicobacter pylori infection. The biopsy specimens were
fixed in 10% formalin at the time of the endoscopy. All
endoscopies were performed by a single gastroenterolo-
gist who was aware that the patient had a positive TTG
test.
In the Pathology laboratory, the specimens had been rou-
tinely oriented and embedded in paraffin wax with stand-
ard sections at three levels. The duodenal histology was
studied with haematoxylin and eosin stains. The intraepi-
thelial lymphocytes (IELs) were counted using CD3 stain-
ing. The histology was reported using the modified Marsh
criteria [5]. Marsh classification of the histologic changes
of celiac disease include Type 0 or pre-infiltrative stage
(normal), Type 1 or infiltrative lesion (increased intraepi-
thelial lymphocytes i.e. >30 lymphocytes per 100 entero-
cytes), Type 2 or hyperplastic lesion (Type 1+ hyperplastic
crypts), Type 3 or destructive lesion (Type 2 + variable
degree of villous atrophy) and Type 4 or hypoplastic
lesion (total villous atrophy with crypt hypoplasia). Type
3 has been modified to include Type 3a (partial villous
atrophy), Type 3b (subtotal villous atrophy) and Type 3c
(total villous atrophy). As is the routine in our institution,
the pathologists studying the biopsies had been provided
with a standard laboratory requisition with details of the
tissue specimens and clinical information that the patient
had a positive serological test and was being investigated
for celiac disease.
The study was approved by the Research Ethics Board of
the IWK Health Centre, Dalhousie University.
Results
The review included thirty-five patients (14 males, 21
females). The mean age was 8.1 (± 4.7) years, range 1.3 to
18.7 years. The most common presenting symptoms were
abdominal pain (40%) and diarrhoea (14.2%). In 20%, a
screening serological test was done because the patient
belonged to a high-risk population including having a
positive family history, type-1 diabetes or Down syn-
drome. Most of these patients also had some mild symp-
toms.
Of the 35 patents, 31 (88.6%) had abnormal distal duo-
denal biopsies (Group I) and 4 (11.4%) had normal distal
duodenal but abnormal bulb biopsies (Group II). The
clinical, endoscopic and histological features of all
patients (n = 35) are shown in Table 1.
In the thirty-one patients from Group I, one patient had
Marsh type 1, one had Marsh type 2 and twenty-nine had
Marsh type 3 lesion. All but two patients with abnormal
distal duodenal biopsies also had abnormal bulb biop-
sies. Both these patients had Marsh type 0 lesion in the
bulb and Marsh type 3 in the distal duodenum.
The distal duodenum showed gross abnormalities in 25
(81%) of cases in Group I. These are listed in Table 1 and
included isolated scalloping of mucosal folds (n = 7),
mosaic pattern (n = 5), and a combination of scalloping
and mosaic appearance (n = 9). The remaining cases
showed various combinations of nodularity, erythema
and ulcerations, along with the above changes. Gross
abnormalities of the duodenal bulb were present in 12
(38.7%) patients in this Group. These included nodularity
(n = 5), mosaic appearance (n = 2), and a combination of
both changes (n = 2). Mucosal friability, edema and ery-
thema were present in one patient each. None of the
patients in the group had Helicobacter pylori infection.
There was no concern raised in the Pathology reports
regarding a lack of sufficient biopsy tissue in any patient.
Group II consisted of four patients who had normal distal
duodenal biopsies (Marsh type 0) but abnormal bulb
biopsies. Of these four patients, one had Marsh type 2 and
the other three had Marsh type 3 lesion. The clinical andBMC Gastroenterology 2009, 9:78 http://www.biomedcentral.com/1471-230X/9/78
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pathological characteristics of these patients are shown in
Table 1. Grossly, the duodenal bulb was completely nor-
mal in one patient; the other three had mild changes with
patchy erythema, nodularity and mosaic appearance with
friability respectively. The distal duodenum was grossly
normal in all. None of the patients in the group had Heli-
cobacter pylori infection.
Marsh type 1 (infiltrative changes) is non-specific and not
diagnostic for celiac disease. The patient # 4 in Group 1
had only Marsh type 1 both in the bulb and distal duode-
num. However, this patient had type-1 diabetes (a high
risk group for celiac disease) and abdominal pain with a
positive TTG antibody. Given all these factors, it was felt
that the patient most likely has celiac disease. The evi-
dence that Marsh type 2 (hyperplastic changes) is a dis-
tinctive feature of celiac disease is not very clear. The
presence of Marsh type 2 changes on intestinal biopsy is
suggestive of celiac disease and the diagnosis is strength-
ened by the presence of positive serological tests (3). The
patient in Group I with Marsh type 2 lesion had abdomi-
nal pain, slow growth, anemia and a positive TTG anti-
body. The patient in Group II with Marsh type 2 lesion
had poor growth and a positive TTG antibody. It was felt
Table 1: Clinical, endoscopic and histological features of all patients (n = 35).
No. Age Sex Other Diagnoses Duodenal Bulb Distal Duodenum





1) 12.5 M friability 3b mosaic, scalloping 3b
2) 3.7 M Type 1 diabetes normal 1 normal 3a
3) 1.8 M normal 3c normal 3c
4) 10.7 F Type 1 diabetes normal 1 normal 1
5) 11.9 M normal 3a mosaic, scalloping 3a
6) 7 F edema 3b mosaic, scalloping 3b
7) 2.2 M normal 3c mosaic, scalloping 3b
8) 13.8 M Type 1 diabetes normal 3a mild scalloping 3a
9) 5.4 F erythema 3a normal 3a
10) 6.8 F normal 3a mild scalloping 3a
11) 2.5 F nodularity 3b scalloping 3b
12) 1.3 M normal 3b mosaic, scalloping 3b
13) 1.6 F normal 3b mosaic 3b
14) 10.3 M IgA nephropathy nodularity 0 scalloping 3b
15) 4.5 M normal 3b nodularity, scalloping 3b
16) 11.5 F Type 1 diabetes normal 3b mosaic 3b
17) 7.3 F normal 2 erythema, scalloping 2
18) 7.2 F Down syndrome nodularity 0 mosaic, scalloping 3a
19) 18.8 M Type 1 diabetes nodularity 3a mosaic, scalloping 3a
20) 12.3 F nodularity 3c mosaic, nodularity 3c
21) 5.6 M normal 3a mosaic, nodularity 3a
22) 13.2 M nodularity, mosaic 3c normal 3b
23) 7.1 F Type 1 diabetes normal 3c mosaic 3c
24) 2.6 F normal 3a scalloping 3a
25) 1.8 F normal 3c mosaic, scalloping 3c
26) 5.4 M mosaic 3c mosaic 3a
27) 14.2 F mosaic 3c scalloping 3b
28) 11.1 F nodularity, mosaic 3c scalloping 3a
29) 9 F normal 3a mosaic, scalloping 3a
30) 17.7 F Type 1 diabetes normal 3a mosaic 3a
31) 10.1 F normal 3b normal 3b
Group II
1) 10.8 F Type 1 diabetes nodularity 3a normal 0
2) 9.2 M mild erythema 2 normal 0
3) 9.4 F mosaic 3c normal 0
4) 4.6 F normal 3c normal 0
All patients had a positive TTG antibody.BMC Gastroenterology 2009, 9:78 http://www.biomedcentral.com/1471-230X/9/78
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that there was enough clinical evidence of these being
cases of celiac disease and treatment with gluten-free diet
with observation of response to therapy is warranted.
The histology of the distal duodenum and duodenal bulb
from patient number 1 of Group II is shown in Figures 1,
2 and 3, 4 respectively. The routine histology and the IEL
count from the biopsies taken from distal duodenum
were normal (Figures 1 and 2). Figure 3 shows the histol-
ogy of the duodenal bulb mucosa of the same patient.
There is total villous atrophy (Marsh type 3) with a
marked increase in the IELs. This is further confirmed by
the CD3 staining showing almost one IEL per enterocyte
(Figure 4).
The histological confirmation of celiac disease would not
have been possible in the four cases in Group II if only dis-
tal duodenal biopsies had been obtained. A combination
of biopsies from the bulb and the distal duodenum iden-
tified celiac disease in all 35 patients suspected of the dis-
order.
Discussion
The diagnosis of celiac disease is confirmed by the demon-
stration of inflammatory changes in the small intestinal
villi. Since the duodenum and the proximal jejunum are
exposed to the highest concentration of gluten, changes
are more marked in the proximal small intestine than the
distal. In the past, distal duodenal/upper jejunal biopsy
was obtained using Crosby-Watson capsule. However,
with fibreoptic endoscopy, the duodenum is much more
easily accessible for mucosal biopsies. Multiple biopsies
are recommended to help reduce the chances of insuffi-
cient tissue for histological assessment. Biopsies should
be taken even if the duodenal mucosa grossly appears nor-
mal as histology may reveal disease in these cases [6].
Traditionally, for celiac disease, biopsies from the duode-
nal bulb have not been recommended on the assumption
that the histology from this area may be difficult in inter-
pret. The bulb contains more Brunner's glands and lym-
phoid tissue and can have gastric metaplasia compared to
the distal duodenum [7]. The villi may also be shorter and
broader in this area [8,9]. Duodenitis from other causes
may also interfere with interpretation of villous atrophy in
this region. The current guidelines by the professional gas-
troenterological organizations including American Gas-
troenterological Association (Technical Review 2006),
North American Society for Paediatric Gastroenterology,
Hepatology and Nutrition (Practice Guidelines 2005) and
World Gastroenterology Organization (Practice Guide-
lines 2007) recommend four biopsies to be taken from
the distal duodenum for histological examination in
celiac disease [2,3,10].
Since the first classification of the spectrum of villous
lesions in celiac disease by Marsh [11], there have been
several modifications to this criterion. Counting of IELs
can improve the diagnostic yield when the typical villous
atrophy is not present or not detectable due to poor orien-
tation or tangential cutting.
Distal duodenal biopsy of patient #1 in Group II with celiac  disease (hematoxylin & eosin stain) Figure 1
Distal duodenal biopsy of patient #1 in Group II with 
celiac disease (hematoxylin & eosin stain).
Distal duodenal biopsy of the same patient in Group II with  celiac disease showing intraepithelial lymphocytes (CD3  stain) Figure 2
Distal duodenal biopsy of the same patient in Group 
II with celiac disease showing intraepithelial lym-
phocytes (CD3 stain).BMC Gastroenterology 2009, 9:78 http://www.biomedcentral.com/1471-230X/9/78
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The patchy nature of the small intestinal lesion in celiac
disease is increasingly being recognized both in children
and adults [4,7,12-16]. The patchiness of lesion in various
parts of the duodenum can be in terms of absence or pres-
ence of villous atrophy [4,12,13] or in the severity of atro-
phy [10]. Since the treatment of celiac disease requires a
lifelong, strict adherence to gluten-free diet, making a
definitive diagnosis of the disorder is of great importance.
In an earlier study, Bonamico et al [4] demonstrated the
patchy nature of the lesion in celiac disease both in chil-
dren who were newly diagnosed and those on a gluten
challenge. In all 95 children at the time of diagnosis of
celiac disease, the bulbar mucosa was involved showing
varying degrees of type 3 villous atrophy. In four (4.2%)
patients, the bulb was the only duodenal area involved
with the other duodenal samples being normal. Prasad et
al have reported similar findings of duodenal bulb
involvement [13]. In 52 children with suspected celiac
disease who underwent one bulb and one distal duodenal
biopsy, all had Marsh type 3 lesions in at least one of the
sites. The authors concluded that duodenal bulb biopsy
was equally diagnostic of celiac disease. More recently, in
a large Italian study of children with celiac disease the
duodenal bulb was involved in all cases of and in some
patients the lesion was only presented in the bulb with
distal duodenum being normal [14]. Villous atrophy lim-
ited to duodenal bulb has also been described in adults
with celiac disease [15,16].
Our study confirms this finding of distal duodenal sparing
in a significant number of patients (11.4%) with celiac
disease. However, in our study, of the 31 patients with
abnormal distal duodenal biopsies, only 29 had abnor-
malities in the bulb while other 2 had normal bulb
mucosa. This testifies further to the patchy nature of the
villous lesion in celiac disease. It is also important to note
that there could be bulb sparing in some patients, albeit
few. This is in contrast to other reports where bulb was
involved in all cases [12-14]. We conclude that biopsies
taken from the bulb alone are not enough as they will
miss some patients.
Recognizing the patchy nature of the disorder, Hopper et
al further studied the number and location of biopsies
required to make a definitive diagnosis of celiac disease
[17]. Nine biopsies were taken; one from the bulb, four
from proximal duodenum and four from distal duode-
num. These were evaluated individually based on their
ability to identify villous atrophy, and on their success
when combined. It was determined that all of the optimal
combinations of biopsy sites included a duodenal bulb
biopsy.
Previous studies had demonstrated the usefulness of duo-
denal bulb biopsies in research settings with a single
pathologist reporting while blinded. The present study is
the first one to examine this practice in routine, everyday
clinical care. A major difference between our and previous
studies is having more than one pathologist involved in
interpreting the biopsies taken from patients in our study.
There were four pathologists reporting on different
Duodenal bulb biopsy of the same patient in Group II with  celiac disease showing intraepithelial lymphocytes (CD3  stain) Figure 4
Duodenal bulb biopsy of the same patient in Group II 
with celiac disease showing intraepithelial lym-
phocytes (CD3 stain).
Duodenal bulb biopsy of patient #1 in Group II with celiac  disease (hematoxylin & eosin stain) Figure 3
Duodenal bulb biopsy of patient #1 in Group II with 
celiac disease (hematoxylin & eosin stain).BMC Gastroenterology 2009, 9:78 http://www.biomedcentral.com/1471-230X/9/78
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patients. All were experienced, academic paediatric
pathologists. Also, none of the pathologists were blinded.
In real life, Pathology Departments of health care institu-
tions will have several pathologists involved in interpret-
ing small intestinal biopsies for celiac disease. It is not
known how often pathologists in academic or community
hospitals do IEL counting routinely. Also, pathologists
may use different modifications of Marsh criteria,
although it is hoped that each pathologist follows one
particular classification to keep consistency in interpreta-
tion of the biopsies. Moreover, the possibility that differ-
ent pathologist interpret duodenal biopsies differently
cannot be excluded. Similarly, one cannot discount the
possibility of an inaccurate interpretation of the biopsies
by a given pathologist. Interpretation of small intestinal
biopsies for celiac disease requires experience and famili-
arity with the spectrum of the histological changes.
Knowledge of the clinical history and the working diagno-
sis of celiac disease may also bias the pathologists in their
interpretation of the findings. Insufficient tissue or poor
orientation of the biopsy specimens can also affect inter-
pretation. However, these phenomenon are likely to be
present and persist in real-life clinical practice. It is impor-
tant to point out that our study is a retrospective review of
biopsy results as reported by the attending pathologist.
The aid of another pathologist for a second opinion was
not sought.
Based on the current and previous studies, we recommend
that biopsies should be taken both from the bulbar and
the distal duodenal mucosa, as these will complement
each other in confirming the diagnosis of celiac disease.
Accepting that villi in the bulb may be less tall, increased
IELs in the presence of a positive serological test will help
improve the likelihood of the diagnosis of celiac disease.
We concur with the suggestion by Hopper et al that mul-
tiple biopsy strategy should incorporate a biopsy from the
duodenal bulb [17]. Moreover, the bulb should be biop-
sied irrespective of its gross appearance. We speculate that
some patients considered to have a "false-positive" sero-
logical test may, in fact, truly have celiac disease. The diag-
nosis could have been missed in these cases as the
biopsies are taken routinely only from the distal duode-
num and not from the bulb.
Conclusion
In conclusion, this study confirms previous reports that
villous atrophy can be patchy in pediatric patients with
celiac disease with duodenal bulb mucosa being the only
area showing histological changes in some cases. The cur-
rent recommendations regarding the site of biopsies need
to be revised as they may lead to a false-negative diagnosis
with significant implications for the patient. The optimal
strategy for detecting villous changes should include biop-
sies not only from the distal duodenum but also from the
bulb to improve the diagnostic yield. Biopsies taken from
both sites can confirm histological diagnosis in all cases of
celiac disease in clinical practice.
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